Introduction
The Central Asian region has shown steady growth in the pharmaceutical sector in recent years.
Key trends
The markets of Uzbekistan, Kazakhstan, and Kyrgyzstan are creating new opportunities for foreign investors. Government programs aimed at developing local manufacturing also play an important role.
- Rising share of generic medicines
- Investment in local manufacturing
- Digitalization and electronic registration
Opportunities
- 1. Establishing local partnerships
- 2. Expanding distribution networks
- 3. Leveraging digital sales channels
Conclusion
By 2025, the region's market is expected to become even more open and competitive.
